Envista (NVST) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Company Overview - Envista (NVST) is expected to report a year-over-year decline in earnings, with a projected EPS of $0.23, reflecting a decrease of -20.7% compared to the previous year [3] - Revenue for the upcoming quarter is anticipated to be $646.15 million, which represents a slight increase of 0.1% from the same quarter last year [3] Earnings Expectations - The consensus EPS estimate has been revised down by 0.57% over the last 30 days, indicating a reassessment by analysts [4] - The Most Accurate Estimate for Envista is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +2.22%, suggesting a likelihood of beating the consensus EPS estimate [10][11] Historical Performance - In the last reported quarter, Envista exceeded the expected EPS of $0.09 by delivering $0.12, resulting in a surprise of +33.33% [12] - Over the past four quarters, Envista has only beaten consensus EPS estimates once [13] Market Sentiment - The upcoming earnings report is set to be released on February 5, and the stock may experience upward movement if the results exceed expectations, while a miss could lead to a decline [2] - The company's current Zacks Rank is 3, indicating a hold position, which suggests a moderate outlook for the stock [11] Industry Context - In comparison, BellRing Brands (BRBR), another player in the Zacks Medical - Products industry, is expected to post earnings of $0.47 per share, reflecting a year-over-year increase of +9.3% [17] - BellRing Brands has an Earnings ESP of 2.15% but carries a Zacks Rank of 4 (Sell), making it difficult to predict a beat on the consensus EPS estimate [18]